• White matter integrity disrupted in peop

    From ScienceDaily@1:317/3 to All on Tue Oct 12 21:30:46 2021
    White matter integrity disrupted in people with Alzheimer's gene
    mutation

    Date:
    October 12, 2021
    Source:
    Radiological Society of North America
    Summary:
    The structural integrity of the brain's white matter as measured
    with an advanced MRI technique is lower in cognitively normal people
    who carry a genetic mutation associated with Alzheimer's disease
    than it is in non- carriers, according to a new study. Researchers
    said the findings show the promise of widely available imaging
    techniques in helping to understand early structural changes in
    the brain before symptoms of dementia become apparent.



    FULL STORY ==========================================================================
    The structural integrity of the brain's white matter as measured with
    an advanced MRI technique is lower in cognitively normal people who
    carry a genetic mutation associated with Alzheimer's disease than it is
    in non- carriers, according to a study in Radiology. Researchers said
    the findings show the promise of widely available imaging techniques
    in helping to understand early structural changes in the brain before
    symptoms of dementia become apparent.


    ========================================================================== People who carry the autosomal dominant Alzheimer disease (ADAD) mutation
    have a higher risk of Alzheimer's disease, a type of dementia that
    affects about one in nine people in the United States. The mutation is
    linked to a buildup of abnormal protein called amyloid-beta in the brain
    that affects both the gray matter and the signal-carrying white matter.

    "It's thought that the amyloid deposition in the gray matter could disrupt
    its function, and as a result the white matter won't function correctly
    or could even atrophy," said study lead author Jeffrey W. Prescott, M.D., Ph.D., neuroradiologist at the MetroHealth Medical Center in Cleveland.

    An earlier study by Dr. Prescott and colleagues on patients with
    sporadic Alzheimer's disease, which comprises 99% of cases, found that
    white matter structural connectivity, as measured with an MRI technique
    called diffusion tensor imaging (DTI), degraded significantly as patients developed more amyloid burden.

    "The current work extends these results by showing that similar
    findings are detectable in asymptomatic at-risk patients," said Jeffrey
    R. Petrella, M.D., professor of radiology at Duke University and senior
    author on both studies.

    In the new study, Dr. Prescott and colleagues used data from the
    Dominantly Inherited Alzheimer Network (DIAN) to compare ADAD mutation
    carriers with non- carriers to see if there were changes in structural connectivity that could be related to the mutation.



    ==========================================================================
    The study participants included 30 mutation carriers, mean age 34 years,
    and 38 non-carriers, mean age 37. The participants all had normal
    cognition when they underwent structural brain MRI and DTI.

    Analysis showed that mutation carriers had lower structural connectivity
    in the frontoparietal control network, which connects areas mainly in
    the parietal and frontal lobes, two regions known to be involved with Alzheimer's disease. Among mutation carriers, there was a correlation
    between expected years until onset of symptoms and white matter structural connectivity in the frontoparietal control network, even when controlling
    for amyloid plaque burden.

    "This suggests that DTI measures of network integrity may serve as a
    surrogate for the brain's resilience to pathologic attack," Dr. Petrella
    said.

    "We used a network measurement called global efficiency, in which a
    decreased efficiency can be taken as a breakdown in the organization of
    the network," Dr.

    Prescott added. "The results show that for mutation carriers, global
    efficiency would decrease significantly as they approach the estimated
    age of symptom onset." The study findings support a potential role for imaging-based identification of structural changes of the brain in people
    at genetic risk for early-onset Alzheimer's disease in understanding
    how genes influence the disease process that leads to dementia.

    "This shows the potential of MRI as an evaluation tool in patients who are deemed at-risk for Alzheimer's disease before they develop symptoms," Dr.

    Prescott said. "Use of these advanced MRI techniques could help further
    refine identification of at-risk patients and risk measurements."
    The findings also point to a role for imaging in studying therapeutic
    drugs to treat Alzheimer's disease. While the majority of trials so far
    have been performed with patients who already have Alzheimer's disease or cognitive impairment, earlier identification and treatment of patients
    at risk represents a more promising avenue for preventing or at least
    delaying the onset of dementia.

    "One potential clinical use of this study tool would be to add
    quantitative information to risk factors like family history and use that
    to help identify patients early, when they may benefit from treatment,"
    Dr. Prescott said. "But until we have an effective treatment, we will
    have to wait for that to be implemented." The researchers hope to do a follow-up using advanced imaging and updated data from the DIAN network to evaluate the progression of Alzheimer's disease in the study participants.

    ========================================================================== Story Source: Materials provided by
    Radiological_Society_of_North_America. Note: Content may be edited for
    style and length.


    ========================================================================== Journal Reference:
    1. Jeffrey W. Prescott, P. Murali Doraiswamy, Dragan Gamberger, Tammie
    Benzinger, Jeffrey R. Petrella. Diffusion Tensor MRI Structural
    Connectivity and PET Amyloid Burden in Preclinical Autosomal
    Dominant Alzheimer Disease: The DIAN Cohort. Radiology, 2021; DOI:
    10.1148/ radiol.2021210383 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2021/10/211012102649.htm

    --- up 5 weeks, 5 days, 8 hours, 25 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)